1. Home
  2. AAME vs SCLX Comparison

AAME vs SCLX Comparison

Compare AAME & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$1.34

Market Cap

34.3M

Sector

Finance

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

BUY

Current Price

$2.48

Market Cap

27.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AAME
SCLX
Founded
1968
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
27.9M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
AAME
SCLX
Price
$1.34
$2.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 865.2K
41.0K
Earning Date
10-16-2026
11-13-2026
Dividend Yield
★ 1.27%
N/A
EPS Growth
★ 221.74
N/A
EPS
★ 0.28
N/A
Revenue
★ $210,440,000.00
$30,253,000.00
Revenue This Year
N/A
$118.16
Revenue Next Year
N/A
$186.31
P/E Ratio
$5.71
★ N/A
Revenue Growth
★ 11.80
N/A
52 Week Low
$1.03
$2.45
52 Week High
$3.24
$27.00

Technical Indicators

Market Signals
Indicator
AAME
SCLX
Relative Strength Index (RSI) 50.21 16.71
Support Level $1.26 N/A
Resistance Level $1.66 $7.77
Average True Range (ATR) 0.12 0.25
MACD 0.04 -0.01
Stochastic Oscillator 46.61 5.06

Price Performance

Historical Comparison
AAME
SCLX

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: